Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose dexamethasone vs prednisolone in untreated ITP
NCT00451594Phase 3Completed
- Sponsor
- Japan Adult Leukemia Study Group
- Start
- Sep 2005
- Primary completion
- Dec 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dexamethasone in immune thrombocytopenia (ITP), sponsored by Japan Adult Leukemia Study Group. Primary endpoints: Response rate at 6 years and Platelet count at 6 years. Started Sep 2005; status: completed.
02
Drugs
dexamethasone
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT00451594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00451594.